Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data

Marscha S. Holleman, Carin A. Uyl-de Groot, Stephen Goodall, Naomi van der Linden

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

27 Downloads (Pure)

Keywords

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{2b21d1eb746644c497c4b41259330632,

title = "Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data",

keywords = "n/a OA procedure",

author = "Holleman, {Marscha S.} and {Uyl-de Groot}, {Carin A.} and Stephen Goodall and {van der Linden}, Naomi",

year = "2019",

month = mar,

doi = "10.1016/j.jval.2018.08.007",

language = "English",

volume = "22",

pages = "322--331",

journal = "Value in health",

issn = "1098-3015",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data

AU - Holleman, Marscha S.

AU - Uyl-de Groot, Carin A.

AU - Goodall, Stephen

AU - van der Linden, Naomi

PY - 2019/3

Y1 - 2019/3

KW - n/a OA procedure

U2 - 10.1016/j.jval.2018.08.007

DO - 10.1016/j.jval.2018.08.007

M3 - Article

SN - 1098-3015

VL - 22

SP - 322

EP - 331

JO - Value in health

JF - Value in health

IS - 3

ER -